I agree that this site is using cookies. You can find further informations here.
X
Rantala, Juha K.
309  results:
Search for persons X
?
1

Assessment of targeted therapy opportunities in sinonasal c..:

Lehtinen, Noora ; Suhonen, Janne ; Rice, Kiesha...
Translational Oncology.  44 (2024)  - p. 101935 , 2024
Link: https://doi.org/10.1016/..
 
?
2

In-vitro assays for immuno-oncology drug efficacy assessmen..:

Rahman, Md Marufur ; Wells, Greg ; Rantala, Juha K....
Expert Review of Clinical Immunology.  20 (2024)  8 - p. 821-838 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Defined extracellular matrix compositions support stiffness..:

Conway, James R. W. ; Isomursu, Aleksi ; Follain, Gautier...
Proceedings of the National Academy of Sciences.  120 (2023)  43 - p. , 2023
Link: https://doi.org/10.1073/..
 
?
4

FBXL12 degrades FANCD2 to regulate replication recovery and..:

Brunner, Andrä ; Li, Qiuzhen ; Fisicaro, Samuele...
Molecular Cell.  83 (2023)  20 - p. 3720-3739.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Cisplatin overcomes radiotherapy resistance in OCT4-express..:

Routila, Johannes ; Qiao, Xi ; Weltner, Jere...
Oral Oncology.  127 (2022)  - p. 105772 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Ex vivo analysis of DNA repair targeting in extreme rare cu..:

Mäkelä, Rami ; Härmä, Ville ; Fajardo, Nibal Badra...
Oncotarget.  12 (2021)  11 - p. 1100-1109 , 2021
Link: https://doi.org/10.18632..
 
?
7

Ex Vivo Drug Screening Informed Targeted Therapy for Metast..:

Nykänen, Noora ; Mäkelä, Rami ; Arjonen, Antti...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
8

Substrate-biased activity-based probes identify proteases t..:

Kryza, Thomas ; Khan, Tashbib ; Lovell, Scott...
Nature Chemical Biology.  17 (2021)  7 - p. 776-783 , 2021
Link: https://doi.org/10.1038/..
 
?
9

PTEN and DNA-PK determine sensitivity and recovery in respo..:

Brunner, Andrä ; Suryo Rahmanto, Aldwin ; Johansson, Henrik...
eLife.  9 (2020)  - p. , 2020
Link: https://doi.org/10.7554/..
 
?
10

Ex vivo assessment of targeted therapies in a rare metastat..:

Mäkelä, Rami ; Arjonen, Antti ; Suryo Rahmanto, Aldwin...
Neoplasia.  22 (2020)  9 - p. 390-398 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Ex vivo modelling of drug efficacy in a rare metastatic ura..:

Mäkelä, Rami ; Arjonen, Antti ; Härmä, Ville...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
12

Image-based ex vivo drug screen to assess targeted therapie..:

Arjonen, Antti ; Mäkelä, Rami ; Härmä, Ville...
Lung Cancer.  145 (2020)  - p. 27-32 , 2020
Link: https://doi.org/10.1016/..
 
?
13

MHC class I loaded ligands from breast cancer cell lines: A..:

Rozanov, Dmitri V. ; Rozanov, Nikita D. ; Chiotti, Kami E....
Journal of Proteomics.  176 (2018)  - p. 13-23 , 2018
Link: https://doi.org/10.1016/..
 
?
14

High-throughput RNAi screen in Ewing sarcoma cells identifi..:

He, Tao ; Surdez, Didier ; Rantala, Juha K....
Gene.  596 (2017)  - p. 137-146 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Metabolic reprogramming ensures cancer cell survival despit..:

Lue, Hui-wen ; Podolak, Jennifer ; Kolahi, Kevin...
Genes & Development.  31 (2017)  20 - p. 2067-2084 , 2017
Link: https://doi.org/10.1101/..
 
1-15